Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Sanofi Winthrop Industrie

Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria
From Sanofi Winthrop Industrie
Via GlobeNewswire
Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD
From Sanofi Winthrop Industrie
Via GlobeNewswire
Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
From Sanofi Winthrop Industrie
Via GlobeNewswire
Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines
From Sanofi Winthrop Industrie
Via GlobeNewswire
Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors
From Sanofi Winthrop Industrie
Via GlobeNewswire
Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
From Sanofi Winthrop Industrie
Via GlobeNewswire
Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA
From Sanofi Winthrop Industrie
Via GlobeNewswire
Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
From Sanofi Winthrop Industrie
Via GlobeNewswire
Press Release: Availability of the Q1 2025 Aide mémoire
From Sanofi Winthrop Industrie
Via GlobeNewswire
Press Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline
From Sanofi Winthrop Industrie
Via GlobeNewswire
Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
From Sanofi Winthrop Industrie
Via GlobeNewswire
Press release: Sanofi successfully prices EUR 1.5 billion of bond issue
From Sanofi Winthrop Industrie
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.